KRMD Quote, Financials, Valuation and Earnings

Alphatec Holdings has a net margin of -17.66% compared to KORU Medical Systems's net margin of -30.68%. KORU Medical Systems's return on equity of -32.71% beat Alphatec Holdings's return on equity of -691.37%.

KORU Medical Systems has a consensus price target of $5.50, signalling upside risk potential of 67.17%. On the other hand Alphatec Holdings has an analysts' consensus of $18.21 which suggests that it could grow by 42.92%. Given that KORU Medical Systems has higher upside potential than Alphatec Holdings, analysts believe KORU Medical Systems is more attractive than Alphatec Holdings.

KORU Medical Systems has a beta of 0.392, which suggesting that the stock is 60.809% less volatile than S&P 500. In comparison Alphatec Holdings has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.249%.

KORU Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KORU Medical Systems pays -- of its earnings as a dividend. Alphatec Holdings pays out -- of its earnings as a dividend.

KORU Medical Systems quarterly revenues are $8.8M, which are smaller than Alphatec Holdings quarterly revenues of $169.2M. KORU Medical Systems's net income of -$1.6M is higher than Alphatec Holdings's net income of -$51.9M. Notably, KORU Medical Systems's price-to-earnings ratio is -- while Alphatec Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KORU Medical Systems is 4.48x versus 2.86x for Alphatec Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Baxter International has a net margin of -17.66% compared to KORU Medical Systems's net margin of 4.8%. KORU Medical Systems's return on equity of -32.71% beat Baxter International's return on equity of -7.38%.

KORU Medical Systems has a consensus price target of $5.50, signalling upside risk potential of 67.17%. On the other hand Baxter International has an analysts' consensus of $38.68 which suggests that it could grow by 23.97%. Given that KORU Medical Systems has higher upside potential than Baxter International, analysts believe KORU Medical Systems is more attractive than Baxter International.

KORU Medical Systems has a beta of 0.392, which suggesting that the stock is 60.809% less volatile than S&P 500. In comparison Baxter International has a beta of 0.628, suggesting its less volatile than the S&P 500 by 37.167%.

KORU Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Baxter International offers a yield of 2.95% to investors and pays a quarterly dividend of $0.17 per share. KORU Medical Systems pays -- of its earnings as a dividend. Baxter International pays out -90.91% of its earnings as a dividend.

KORU Medical Systems quarterly revenues are $8.8M, which are smaller than Baxter International quarterly revenues of $2.6B. KORU Medical Systems's net income of -$1.6M is lower than Baxter International's net income of $126M. Notably, KORU Medical Systems's price-to-earnings ratio is -- while Baxter International's PE ratio is 167.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KORU Medical Systems is 4.48x versus 1.34x for Baxter International. Usually stocks with elevated PS ratios are considered overvalued.

electroCore has a net margin of -17.66% compared to KORU Medical Systems's net margin of -45.81%. KORU Medical Systems's return on equity of -32.71% beat electroCore's return on equity of -147.07%.

KORU Medical Systems has a consensus price target of $5.50, signalling upside risk potential of 67.17%. On the other hand electroCore has an analysts' consensus of $24.48 which suggests that it could grow by 371.68%. Given that electroCore has higher upside potential than KORU Medical Systems, analysts believe electroCore is more attractive than KORU Medical Systems.

KORU Medical Systems has a beta of 0.392, which suggesting that the stock is 60.809% less volatile than S&P 500. In comparison electroCore has a beta of 0.916, suggesting its less volatile than the S&P 500 by 8.354%.

KORU Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. electroCore offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KORU Medical Systems pays -- of its earnings as a dividend. electroCore pays out -- of its earnings as a dividend.

KORU Medical Systems quarterly revenues are $8.8M, which are larger than electroCore quarterly revenues of $7M. KORU Medical Systems's net income of -$1.6M is higher than electroCore's net income of -$3.2M. Notably, KORU Medical Systems's price-to-earnings ratio is -- while electroCore's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KORU Medical Systems is 4.48x versus 1.54x for electroCore. Usually stocks with elevated PS ratios are considered overvalued.

Owlet has a net margin of -17.66% compared to KORU Medical Systems's net margin of -44.19%. KORU Medical Systems's return on equity of -32.71% beat Owlet's return on equity of --.

KORU Medical Systems has a consensus price target of $5.50, signalling upside risk potential of 67.17%. On the other hand Owlet has an analysts' consensus of $10.17 which suggests that it could grow by 143.81%. Given that Owlet has higher upside potential than KORU Medical Systems, analysts believe Owlet is more attractive than KORU Medical Systems.

KORU Medical Systems has a beta of 0.392, which suggesting that the stock is 60.809% less volatile than S&P 500. In comparison Owlet has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

KORU Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Owlet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KORU Medical Systems pays -- of its earnings as a dividend. Owlet pays out -- of its earnings as a dividend.

KORU Medical Systems quarterly revenues are $8.8M, which are smaller than Owlet quarterly revenues of $20.5M. KORU Medical Systems's net income of -$1.6M is higher than Owlet's net income of -$9.1M. Notably, KORU Medical Systems's price-to-earnings ratio is -- while Owlet's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KORU Medical Systems is 4.48x versus 0.60x for Owlet. Usually stocks with elevated PS ratios are considered overvalued.